
    
      16 weeks

        -  V1 (week 0): Inclusion visit.

        -  V2 (Week 4): Irbesartan/amlodipine 150/5 mg fixed combination visit

        -  V3 (Week 8): 1st dose escalation for patients in whom OBPM is not controlled (SBP ≥ 140
           mmHg or DBP ≥ 90mmHg,

        -  V4 (Week 12): 2nd Dose escalation visit for patients in whom OBPM is not controlled (SBP
           ≥ 140 mmHg or DBP ≥ 90mmHg

        -  V5 (Week 16): End of study visit
    
  